SPPI logo

Spectrum Pharmaceuticals (SPPI) Cash From Investing

Annual CFI

-$26.72 M
-$135.43 M-124.58%

December 31, 2022

Summary

Performance

1-Year Change

-124.58%

3-Year Change

-183.51%

5-Year Change

-2371.6%

15-Year Change

-2371.6%

SPPI Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$108.71 M
SPPI annual cash flow from investing activities is currently -124.58% below its historical high of $108.71 million

3-Year Low

-$26.72 M
SPPI annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
SPPI previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
SPPI next annual earnings announcement has not yet been scheduled

OtherSPPIcash flowmetrics:

Annual CFF

$75.59 M
SPPI annual cash flow from financing activities is $75.59 million

Annual CFO

-$96.99 M
SPPI annual cash flow from operations is -$96.99 million

Annual FCF

-$97.26 M
SPPI annual free cash flow is -$97.26 million

Annual CAPEX

$273.00 K
SPPI annual capital expenditures is $273.00 thousand

Quarterly CFI

$31.33 M
+$21.81 M+228.99%

March 31, 2023

Summary

Performance

3-Month Change

+228.99%

1-Year Change

+7220.09%

3-Year Change

-20.41%

5-Year Change

+668.46%

SPPI Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$158.45 M
SPPI quarterly cash flow from investing activities is currently -80.23% below its historical high of $158.45 million

3-Year Low

-$34.90 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
SPPI previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
SPPI next earnings announcement has not yet been scheduled

OtherSPPIcash flowmetrics:

Quarterly CFF

$2.11 M
SPPI quarterly cash flow from financing activities is $2.11 million

Quarterly CFO

-$21.44 M
SPPI quarterly cash flow from operations is -$21.44 million

Quarterly FCF

-$21.55 M
SPPI quarterly free cash flow is -$21.55 million

Quarterly CAPEX

$108.00 K
SPPI quarterly capital expenditures is $108.00 thousand

TTM CFI

$4.18 M
+$30.90 M+115.66%

March 31, 2023

Summary

Performance

3-Month Change

+115.66%

1-Year Change

-94.23%

3-Year Change

+104.8%

5-Year Change

-86.92%

SPPI TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$155.75 M
SPPI TTM cash flow from investing activities is currently -97.31% below its historical high of $155.75 million

3-Year Low

-$26.72 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
SPPI previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
SPPI next earnings announcement has not yet been scheduled

OtherSPPIcash flowmetrics:

TTM CFF

$57.70 M
SPPI TTM cash flow from financing activities is $57.70 million

TTM CFO

-$88.13 M
SPPI TTM cash flow from operations is -$88.13 million

TTM FCF

-$88.47 M
SPPI TTM free cash flow is -$88.47 million

TTM CAPEX

$342.00 K
SPPI TTM capital expenditures is $342.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SPPI Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-124.6%+7220.1%-94.2%
3 y3 years-183.5%-20.4%+104.8%
5 y5 years-2371.6%+668.5%-86.9%

SPPI Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-124.6%at lowat high-211.4%-96.2%-738.6%
5 y5-year-124.6%at low-27.1%-296.8%-96.2%-2181.6%
alltimeall time-124.6%+329.3%-80.2%-531.5%-97.3%-3381.8%

Spectrum Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2023
-
$31.33 M(+229.0%)
$4.18 M(-115.7%)
Dec 2022
-$26.72 M(-124.6%)
$9.52 M(-638.6%)
-$26.72 M(+6.9%)
Sep 2022
-
-$1.77 M(-94.9%)
-$25.00 M(+366.7%)
Jun 2022
-
-$34.90 M(-8254.4%)
-$5.36 M(-107.4%)
Mar 2022
-
$428.00 K(-96.2%)
$72.50 M(-33.3%)
Dec 2021
$108.71 M(+501.5%)
$11.24 M(-37.1%)
$108.71 M(+9.4%)
Sep 2021
-
$17.88 M(-58.4%)
$99.34 M(+401.1%)
Jun 2021
-
$42.95 M(+17.2%)
$19.82 M(+29.1%)
Mar 2021
-
$36.64 M(+1857.5%)
$15.35 M(-15.0%)
Dec 2020
$18.07 M(-43.5%)
$1.87 M(-103.0%)
$18.07 M(-200.8%)
Sep 2020
-
-$61.64 M(-260.2%)
-$17.93 M(-124.0%)
Jun 2020
-
$38.48 M(-2.2%)
$74.80 M(-185.9%)
Mar 2020
-
$39.36 M(-215.3%)
-$87.10 M(-372.2%)
Dec 2019
$31.99 M(+2230.1%)
-$34.13 M(-209.8%)
$31.99 M(-49.6%)
Sep 2019
-
$31.09 M(-125.2%)
$63.41 M(+96.2%)
Jun 2019
-
-$123.42 M(-177.9%)
$32.32 M(-79.2%)
Mar 2019
-
$158.45 M(-5944.7%)
$155.75 M(>+9900.0%)
Dec 2018
$1.37 M(-227.0%)
-$2.71 M(<-9900.0%)
$1.37 M(-65.8%)
Sep 2018
-
$0.00(-100.0%)
$4.02 M(+6.5%)
Jun 2018
-
$7000.00(-99.8%)
$3.77 M(+20.4%)
Mar 2018
-
$4.08 M(-6185.1%)
$3.13 M(-389.8%)
Dec 2017
-$1.08 M(+59.2%)
-$67.00 K(-72.7%)
-$1.08 M(-33.7%)
Sep 2017
-
-$245.00 K(-61.2%)
-$1.63 M(+17.7%)
Jun 2017
-
-$632.00 K(+361.3%)
-$1.39 M(+88.1%)
Mar 2017
-
-$137.00 K(-77.8%)
-$737.00 K(+8.5%)
Dec 2016
-$679.00 K(-123.9%)
-$617.00 K(<-9900.0%)
-$679.00 K(+830.1%)
Sep 2016
-
$0.00(-100.0%)
-$73.00 K(-102.4%)
Jun 2016
-
$17.00 K(-121.5%)
$2.99 M(+5.3%)
Mar 2016
-
-$79.00 K(+618.2%)
$2.84 M(-0.0%)
Dec 2015
$2.84 M(-113.0%)
-$11.00 K(-100.4%)
$2.84 M(-112.7%)
Sep 2015
-
$3.06 M(-2384.3%)
-$22.28 M(+3.1%)
Jun 2015
-
-$134.00 K(+71.8%)
-$21.61 M(+0.1%)
Mar 2015
-
-$78.00 K(-99.7%)
-$21.60 M(-1.1%)
Dec 2014
-$21.84 M(+52.4%)
-$25.13 M(-774.5%)
-$21.84 M(-767.7%)
Sep 2014
-
$3.73 M(-3204.2%)
$3.27 M(-128.1%)
Jun 2014
-
-$120.00 K(-62.5%)
-$11.64 M(-20.3%)
Mar 2014
-
-$320.00 K(+2185.7%)
-$14.61 M(+1.9%)
Dec 2013
-$14.33 M(-87.5%)
-$14.00 K(-99.9%)
-$14.33 M(+7.7%)
Sep 2013
-
-$11.19 M(+262.9%)
-$13.30 M(-90.3%)
Jun 2013
-
-$3.08 M(+6906.8%)
-$137.31 M(+18.8%)
Mar 2013
-
-$44.00 K(-104.4%)
-$115.59 M(+0.8%)
Dec 2012
-$114.69 M(<-9900.0%)
$1.01 M(-100.7%)
-$114.69 M(+0.1%)
Sep 2012
-
-$135.19 M(-825.4%)
-$114.60 M(-635.6%)
Jun 2012
-
$18.64 M(+2077.3%)
$21.40 M(+1598.1%)
Mar 2012
-
$856.00 K(-22.3%)
$1.26 M(+68.9%)
Dec 2011
$746.00 K(-107.6%)
$1.10 M(+37.8%)
$746.00 K(-115.9%)
Sep 2011
-
$800.00 K(-153.4%)
-$4.70 M(+7.1%)
Jun 2011
-
-$1.50 M(-538.0%)
-$4.39 M(-139.1%)
Mar 2011
-
$342.00 K(-107.9%)
$11.21 M(-214.0%)
Dec 2010
-$9.83 M(+68.7%)
-$4.34 M(-490.7%)
-$9.83 M(-112.7%)
Sep 2010
-
$1.11 M(-92.1%)
$77.29 M(+297.2%)
Jun 2010
-
$14.10 M(-168.1%)
$19.46 M(-195.3%)
Mar 2010
-
-$20.70 M(-125.0%)
-$20.42 M(+250.3%)
DateAnnualQuarterlyTTM
Dec 2009
-$5.83 M(-76.5%)
$82.78 M(-246.0%)
-$5.83 M(-95.1%)
Sep 2009
-
-$56.72 M(+120.0%)
-$119.68 M(+126.2%)
Jun 2009
-
-$25.78 M(+322.0%)
-$52.92 M(+29.4%)
Mar 2009
-
-$6.11 M(-80.3%)
-$40.90 M(+65.1%)
Dec 2008
-$24.78 M(+437.3%)
-$31.06 M(-409.4%)
-$24.78 M(-271.6%)
Sep 2008
-
$10.04 M(-172.9%)
$14.44 M(+25.2%)
Jun 2008
-
-$13.77 M(-237.5%)
$11.53 M(+1710.0%)
Mar 2008
-
$10.01 M(+22.9%)
$637.00 K(-113.8%)
Dec 2007
-$4.61 M(-69.6%)
$8.15 M(+14.2%)
-$4.61 M(-72.4%)
Sep 2007
-
$7.13 M(-128.9%)
-$16.70 M(-13.9%)
Jun 2007
-
-$24.66 M(-617.5%)
-$19.39 M(-301.4%)
Mar 2007
-
$4.76 M(-220.9%)
$9.63 M(-163.5%)
Dec 2006
-$15.16 M(-1983.5%)
-$3.94 M(-188.7%)
-$15.16 M(-67.1%)
Sep 2006
-
$4.44 M(+1.9%)
-$46.15 M(-8.9%)
Jun 2006
-
$4.36 M(-121.8%)
-$50.67 M(+143.0%)
Mar 2006
-
-$20.02 M(-42.7%)
-$20.85 M(-2690.1%)
Dec 2005
$805.00 K(-102.3%)
-$34.93 M(>+9900.0%)
$805.00 K(-343.2%)
Sep 2005
-
-$76.00 K(-100.2%)
-$331.00 K(-100.8%)
Jun 2005
-
$34.18 M(+1995.6%)
$40.12 M(-414.4%)
Mar 2005
-
$1.63 M(-104.5%)
-$12.76 M(-62.9%)
Dec 2004
-$34.40 M(+2518.0%)
-$36.07 M(-189.3%)
-$34.40 M(>+9900.0%)
Sep 2004
-
$40.37 M(-315.9%)
-$218.00 K(-99.5%)
Jun 2004
-
-$18.70 M(-6.6%)
-$40.35 M(+88.9%)
Mar 2004
-
-$20.01 M(+962.7%)
-$21.36 M(+1525.3%)
Dec 2003
-$1.31 M(-121.0%)
-$1.88 M(-884.6%)
-$1.31 M(-434.2%)
Sep 2003
-
$240.00 K(-19.1%)
$393.20 K(-39.2%)
Jun 2003
-
$296.80 K(+821.7%)
$646.50 K(+146.2%)
Mar 2003
-
$32.20 K(-118.3%)
$262.60 K(-95.8%)
Dec 2002
$6.27 M(-357.1%)
-$175.80 K(-135.6%)
$6.27 M(-14.9%)
Sep 2002
-
$493.30 K(-666.4%)
$7.37 M(+0.8%)
Jun 2002
-
-$87.10 K(-101.4%)
$7.32 M(+16.2%)
Mar 2002
-
$6.04 M(+552.1%)
$6.30 M(-358.2%)
Dec 2001
-$2.44 M(-18.3%)
$926.50 K(+112.7%)
-$2.44 M(-56.4%)
Sep 2001
-
$435.60 K(-139.4%)
-$5.59 M(-15.1%)
Jun 2001
-
-$1.11 M(-59.0%)
-$6.59 M(+20.4%)
Mar 2001
-
-$2.70 M(+21.1%)
-$5.47 M(+83.2%)
Dec 2000
-$2.99 M(+77.9%)
-$2.23 M(+298.3%)
-$2.99 M(+218.0%)
Sep 2000
-
-$558.80 K(-5920.8%)
-$939.10 K(-26.7%)
Jun 2000
-
$9600.00(-104.5%)
-$1.28 M(+341.6%)
Mar 2000
-
-$211.40 K(+18.4%)
-$289.90 K(-82.7%)
Dec 1999
-$1.68 M(-1778.5%)
-$178.50 K(-80.2%)
-$1.68 M(+29.1%)
Sep 1999
-
-$900.00 K(-190.0%)
-$1.30 M(+550.0%)
Jun 1999
-
$1.00 M(-162.5%)
-$200.00 K(-85.7%)
Mar 1999
-
-$1.60 M(-900.0%)
-$1.40 M(-1500.0%)
Dec 1998
$100.00 K(-94.4%)
$200.00 K(0.0%)
$100.00 K(-98.7%)
Sep 1998
-
$200.00 K(-200.0%)
$7.60 M(+13.4%)
Jun 1998
-
-$200.00 K(+100.0%)
$6.70 M(-5.6%)
Mar 1998
-
-$100.00 K(-101.3%)
$7.10 M(+294.4%)
Dec 1997
$1.80 M(-123.7%)
$7.70 M(-1200.0%)
$1.80 M(-130.5%)
Sep 1997
-
-$700.00 K(-450.0%)
-$5.90 M(+13.5%)
Jun 1997
-
$200.00 K(-103.7%)
-$5.20 M(-3.7%)
Mar 1997
-
-$5.40 M
-$5.40 M
Dec 1996
-$7.60 M
-
-

FAQ

  • What is Spectrum Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals annual CFI year-on-year change?
  • What is Spectrum Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals quarterly CFI year-on-year change?
  • What is Spectrum Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Spectrum Pharmaceuticals?
  • What is Spectrum Pharmaceuticals TTM CFI year-on-year change?

What is Spectrum Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of SPPI is -$26.72 M

What is the all time high annual CFI for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high annual cash flow from investing activities is $108.71 M

What is Spectrum Pharmaceuticals annual CFI year-on-year change?

Over the past year, SPPI annual cash flow from investing activities has changed by -$135.43 M (-124.58%)

What is Spectrum Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of SPPI is $31.33 M

What is the all time high quarterly CFI for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high quarterly cash flow from investing activities is $158.45 M

What is Spectrum Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, SPPI quarterly cash flow from investing activities has changed by +$30.90 M (+7220.09%)

What is Spectrum Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of SPPI is $4.18 M

What is the all time high TTM CFI for Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals all-time high TTM cash flow from investing activities is $155.75 M

What is Spectrum Pharmaceuticals TTM CFI year-on-year change?

Over the past year, SPPI TTM cash flow from investing activities has changed by -$68.31 M (-94.23%)